InPharmX Inc., DBA University Learning Systems Phone: 1-800-940-5860 Email: info@universitylearning.com
Lake Placid welcome sign surrounded by Adirondack scenery
← All on demand pharmacology CE/CME

On demand pharmacology CE/CME

Therapeutic Highlights 2026 On Demand

FormatSelf-paced onlineRecordedOctober 7–9, 2026AccessAvailable now
Log in to register

About this course

Learn at your own pace.

  • This course provides 15 contact hours  of pharmacy CE and  (1.5 CEU) of live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/CME credit.

  • 15.00 Hours Live AAFP Prescribed credit

  • Recorded in Octoberof 2026

  • Term of Approval is from 10/09/2026 to 12/31/2026


Educational information

Designed for meaningful, practical learning.

Each session provides five hours of credit. Advance registration ends September 7, 2026. In-person and live-stream options are available.

Sessions

Session
2026-10-07 Pharmacotherapeutic Treatment of GI Condition

Wednesday, October 7, 2026

Speaker: Dr. Peter S. Buch Credit hours: 5 ACPE UAN: 0741-0000-26-018-H01-P

Learning objectives
  1. Define the appropriate workup for several interactive cases of acute abdominal pain.
  2. Illustrate the pitfalls in making a diagnosis.
  3. Identify the importance of risk factors in the development of UGI bleeding.
  4. Select appropriate candidates for long term PPI therapy.
  5. Review noninvasive ways of making a H pylori diagnosis.
  6. Manage antibiotic therapy for Helicobacter 2024.
  7. Describe the limitations of colonoscopy.
  8. Recognize the importance of
  9. Describe advanced endoscopic techniques that are used to evaluate GI bleeding.
  10. Recognize the safe use of anti platelet and anticoagulation medications post GI bleeding.
  11. State the best practices that lead to colon cancer prevention.
  12. Review types of polyps and their consequences.
  13. Review the pitfalls of colonoscopy screening.
  14. Show reasonable alternatives to colonoscopy. Non Alcoholic Fatty Liver Disease/ Metabolic
  15. Define Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction Associated Steatohepatitis (MASH).
  16. Identify at risk individuals for MASLD and MASH.
  17. Discuss long term and short term consequences of MASLD and MASH.
  18. Identify treatment options for MASLD and MASH.
2026-10-08 The Art of Deprescribing in People with Profound Autism

Thursday, October 8, 2026

Speaker: Dr. Michael Cummings Credit hours: 5 ACPE UAN: 0741-0000-26-019-H01-P

Learning objectives
  1. Discuss why individuals with profound autism have reduced access to inpatient psychiatric hospitalization.
  2. Define polypharmacy.
  3. Identify three reasons for polypharmacy in people with profound autism.
  4. Apply deprescribing strategies to a clinical case example.
  5. Define diagnostic overshadowing and evaluate factors that may contribute to it using a clinical case example.
  6. Identify three common psychotropic side effects and assess how they contribute to aggression and self-injurious behaviors in people with intellectual disabilities.
  7. Distinguish between affective and mood lability and describe how those differences influence treatment planning.
  8. Describe the diagnostic and treatment differences of catatonia in people with and without an intellectual disability.
  9. Formulate a treatment plan for an individual with profound autism and excited catatonia.
2026-10-09 Mabology 101: The Clinical Science Behind Monoclonal Antibodies

Friday, October 9, 2026

Speaker: Dr. Kelly Jones Credit hours: 5 ACPE UAN: 0741-0000-26-020-H01-P

Learning objectives
  1. 1.Describe the basic pharmacology behind monoclonal antibodies.
  2. Discuss how monoclonal antibodies are made.
  3. Discuss the nomenclature behind naming monoclonal antibodies.
  4. List examples of monoclonal antibodies and the conditions they treat.
  5. Outline in STEPS format (safety, tolerability, efficacy, price, simplicity) several monoclonal antibodies (i.e., Certolizumab, denosumab, new cholesterol medications.)
  6. Discuss the side effects of selected monoclonal antibodies.
  7. Discuss risk factors associated with these new technologies.
  8. List any general patient education.

Faculty

Portrait of Dr. Peter S. Buch, ULS faculty member

Dr. Peter S. Buch, MD, AGAF, FACP

Clinical Gastroenterologist and Educator · GI Educator

A clinical gastroenterologist with more than 30 years of teaching experience. His case-based, interactive style connects evidence with everyday clinical decisions.

Professional profile ↗
Portrait of Dr. Michael Cummings, ULS faculty member

Dr. Michael Cummings, MD

Vice Chair and Assistant Professor of Psychiatry · University at Buffalo

A psychiatrist and educator in the Jacobs School of Medicine and Biomedical Sciences whose clinical teaching includes complex behavioral health and deprescribing.

Professional profile ↗
Portrait of Dr. Kelly Jones, ULS faculty member

Dr. Kelly Jones, PharmD

Board-Certified Pharmacotherapy Specialist

A family-medicine-trained clinical pharmacist with extensive experience translating pharmacotherapy evidence into primary-care practice.

Professional profile ↗

Accreditation

Target audience

Pharmacists, Nurse Practitioners, Physicians, Physician Assistants, Nurses

PHARMACISTS

  • University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. 
  • These programs are accredited for all pharmacists.
  • This course provides 15 hours or 1.5 CEUs.
  • Credit for this course expires on October 9, 2029.

NURSES

  • This course provides 15 hours (1.5 CEU)
  • University Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357:
  • University Learning Systems is approved by CE Broker for Florida, Georgia, Arkansas, District of Columbia, Georgia, New Mexico, and West Virginia, Boards of Nursing. 
  • The same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.

OTHER PROFESSIONS

  • CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

  • CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). 

  • CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians

  • Other healthcare professionals should confirm acceptance and reporting requirements with their licensing or certification board

Requirements and reporting

  • University Learning Systems reports pharmacy credit through CPE Monitor using the participant’s eNABPID number and date of birth.
  • University Learning Systems is approved by CE Broker, for pharmacy, medicine and nursing for participating states,  Tracking #50-11357. Participant's state license number is required for reporting.
  • Credit is based on completed evaluations for registered sessions. 
  • Credit is awarded per session; partial session credit is not available, and breaks are excluded.
  • Other eligible participants receive an applicable statement of credit after completing the required documentation.

Review complete ULS accreditation statements →

Course fees

DescriptionPrice
Default 15 Hours$250

Begin today

Ready when you are.

Log in to register